ParkinsonCanadaV1, Main, Exploration, bibRecord, 003277

The protective role of levodopa in the human substantia nigra

Identifieur interne : 003277 ( Main/Exploration ); précédent : 003276; suivant : 003278

The protective role of levodopa in the human substantia nigra

Auteurs : Ali H. Rajput [Canada]

Source :

Advances in neurology [ 0091-3952 ] ; 2001.

RBID : Pascal:03-0237957

Descripteurs français

Pascal (Inist)
- Parkinson maladie, Prévention, Lévodopa, Homme.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Adult, Animals, Antiparkinson Agents (therapeutic use), Child, Female, Human, Humans, Levodopa, Levodopa (therapeutic use), Male, Middle Aged, Neuroprotective Agents (therapeutic use), Parkinson Disease (drug therapy), Parkinson disease, Prevention, Substantia Nigra (drug effects), Substantia Nigra (physiopathology).
MESH :
- chemical , therapeutic use : Antiparkinson Agents, Levodopa, Neuroprotective Agents.
- drug effects : Substantia Nigra.
- drug therapy : Parkinson Disease.
- physiopathology : Substantia Nigra.
- Adult, Animals, Child, Female, Humans, Male, Middle Aged.

Affiliations:

Canada

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">The protective role of levodopa in the human substantia nigra</title>
<author><name sortKey="Rajput, Ali H" sort="Rajput, Ali H" uniqKey="Rajput A" first="Ali H." last="Rajput">Ali H. Rajput</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Royal University Hospital, University of Saskatchewan</s1>
<s2>Saskatoon, S7N 0W8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Saskatoon, S7N 0W8</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">03-0237957</idno>
<date when="2001">2001</date>
<idno type="stanalyst">PASCAL 03-0237957 INIST</idno>
<idno type="RBID">Pascal:03-0237957</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000A96</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000227</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000A53</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000A53</idno>
<idno type="wicri:doubleKey">0091-3952:2001:Rajput A:the:protective:role</idno>
<idno type="wicri:Area/Main/Merge">003760</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:11553992</idno>
<idno type="wicri:Area/PubMed/Corpus">001587</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001587</idno>
<idno type="wicri:Area/PubMed/Curation">001587</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001587</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001587</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001587</idno>
<idno type="wicri:Area/Ncbi/Merge">000183</idno>
<idno type="wicri:Area/Ncbi/Curation">000183</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000183</idno>
<idno type="wicri:doubleKey">0091-3952:2001:Rajput A:the:protective:role</idno>
<idno type="wicri:Area/Main/Merge">003557</idno>
<idno type="wicri:Area/Main/Curation">003277</idno>
<idno type="wicri:Area/Main/Exploration">003277</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">The protective role of levodopa in the human substantia nigra</title>
<author><name sortKey="Rajput, Ali H" sort="Rajput, Ali H" uniqKey="Rajput A" first="Ali H." last="Rajput">Ali H. Rajput</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Neurology, Royal University Hospital, University of Saskatchewan</s1>
<s2>Saskatoon, S7N 0W8</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Saskatoon, S7N 0W8</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Advances in neurology</title>
<title level="j" type="abbreviated">Adv. neurol.</title>
<idno type="ISSN">0091-3952</idno>
<imprint><date when="2001">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Advances in neurology</title>
<title level="j" type="abbreviated">Adv. neurol.</title>
<idno type="ISSN">0091-3952</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Animals</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Child</term>
<term>Female</term>
<term>Human</term>
<term>Humans</term>
<term>Levodopa</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neuroprotective Agents (therapeutic use)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson disease</term>
<term>Prevention</term>
<term>Substantia Nigra (drug effects)</term>
<term>Substantia Nigra (physiopathology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
<term>Neuroprotective Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Substantia Nigra</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Substantia Nigra</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Animals</term>
<term>Child</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Prévention</term>
<term>Lévodopa</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Rajput, Ali H" sort="Rajput, Ali H" uniqKey="Rajput A" first="Ali H." last="Rajput">Ali H. Rajput</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003277 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003277 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:03-0237957
   |texte=   The protective role of levodopa in the human substantia nigra
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

La maladie de Parkinson au Canada (serveur d'exploration)

The protective role of levodopa in the human substantia nigra

The protective role of levodopa in the human substantia nigra

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.